The CDC told the J&J C-19 vaccine recipients to get a second dose for greater protection against the virus.
The Washington Post reported.
The nearly 17 million Americans who received the one-shot Johnson & Johnson coronavirus vaccine are less protected against serious illness and hospitalizations than those who got the Pfizer-BioNTech and Moderna shots, according to federal data released Tuesday.
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
The latest data suggest Johnson & Johnson recipients should get a booster with one of the messenger RNA vaccines, if they haven’t already done so — and even consider a second messenger RNA booster for the greatest protection. The data come from a Centers for Disease Control and Prevention report that analyzed the results of mix-and-match vaccine-and-booster combinations during a four-month period when the highly transmissible omicron variant was dominant.
Even combining a Johnson & Johnson vaccine with a booster of either Johnson & Johnson, or one of the two messenger RNA vaccines, wasn’t as strong as three shots of the messenger RNA vaccines in preventing emergency room visits or hospitalizations, according to the report.
Shortly after the CDC issued the statement, they authorized the C-19 booster shot of Pfizer and Moderna C-19 vaccines for people 50+ & some specific immunocompromised persons.
Four doses in 2 years. Is this the start of the annual C-19 shots?